Catalyst Biosciences, Inc. (CBIO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 7.12M |
| Enterprise value | -15.58M |
| Trailing P/E | 0.50 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.84 |
| Price/book (mrq) | 0.24 |
| Enterprise value/revenue | -4.82 |
| Enterprise value/EBITDA | -1.28 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.21 |
| 52-week change 3 | -69.23% |
| S&P500 52-week change 3 | -14.12% |
| 52-week high 3 | 2.0900 |
| 52-week low 3 | 0.1900 |
| 50-day moving average 3 | 0.2486 |
| 200-day moving average 3 | 0.9108 |
Share statistics
| Avg vol (3-month) 3 | 1.61M |
| Avg vol (10-day) 3 | 352.81k |
| Shares outstanding 5 | 37.76M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 22.62M |
| % held by insiders 1 | 28.20% |
| % held by institutions 1 | 13.58% |
| Shares short (14 Mar 2023) 4 | 743.13k |
| Short ratio (14 Mar 2023) 4 | 0.3 |
| Short % of float (14 Mar 2023) 4 | 1.98% |
| Short % of shares outstanding (14 Mar 2023) 4 | 1.97% |
| Shares short (prior month 14 Feb 2023) 4 | 263.83k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 1.43 |
| Trailing annual dividend yield 3 | 715.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 11 Jan 2023 |
| Ex-dividend date 4 | 12 Jan 2023 |
| Last split factor 2 | 1:15 |
| Last split date 3 | 12 Feb 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 367.44% |
| Operating margin (ttm) | -1,259.34% |
Management effectiveness
| Return on assets (ttm) | -46.47% |
| Return on equity (ttm) | 26.37% |
Income statement
| Revenue (ttm) | 3.23M |
| Revenue per share (ttm) | 0.10 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | -64.91M |
| EBITDA | -40.39M |
| Net income avi to common (ttm) | 11.88M |
| Diluted EPS (ttm) | 0.3900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 23.09M |
| Total cash per share (mrq) | 0.73 |
| Total debt (mrq) | 381k |
| Total debt/equity (mrq) | 1.30 |
| Current ratio (mrq) | 18.40 |
| Book value per share (mrq) | 0.93 |
Cash flow statement
| Operating cash flow (ttm) | -49.3M |
| Levered free cash flow (ttm) | -35.22M |
© 2023 Yahoo. All rights reserved.
